Wolfe Research Downgrades Ionis Pharmaceuticals to Peer Perform

Benzinga Newsdesk www.benzinga.com Negative 94.7%

Neg 94.7% Neu 0% Pos 0%

Wolfe Research analyst Andy Chen downgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Outperform to Peer Perform.

Comments

No comments yet. Be the first!